help button home button Am J Pathol JNCI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goggins, M.
Right arrow Articles by Hruban, R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goggins, M.
Right arrow Articles by Hruban, R. H.

American Journal of Pathology, Vol 152, 1501-1507, Copyright © 1998 by American Society for Investigative Pathology


REGULAR ARTICLES

Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+

M Goggins, GJ Offerhaus, W Hilgers, CA Griffin, M Shekher, D Tang, TA Sohn, CJ Yeo, SE Kern and RH Hruban
Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.

The clinical and pathological features of carcinomas of the pancreas with DNA replication errors (RER+) have not been characterized. Eighty- two xenografted carcinomas of the pancreas were screened for DNA replication errors using polymerase chain reaction amplification of microsatellite markers. Cases with microsatellite instability in at least two markers of a minimum of five tested were considered RER+. RER status was correlated with histological appearance, karyotype of the carcinomas when available, K-ras mutational status, and patient outcome. Three (3.7%) of the eighty-two carcinomas were RER+. In contrast to typical gland-forming adenocarcinomas of the pancreas, all three RER+ carcinomas were poorly differentiated and had expanding borders and a prominent syncytial growth pattern. Neither a Crohn's- like lymphoid infiltrate nor extracellular mucin production were prominent. Ductal adenocarcinomas of the pancreas typically contain a mutant K-ras gene, yet all three RER+ carcinomas had wild-type K-ras. One of the three RER+ carcinomas was karyotyped and showed a near diploid pattern. All three of the RER+ tumors were removed via Whipple resection. One of the three patients is free of disease 16 months after pancreaticoduodenectomy, one is alive and free of tumor at 52 months but developed two colon carcinomas during this period, and the third died of pancreatic cancer at 4 months. None of the three patients had a family history of colorectal carcinoma. A review of the K-ras wild-type carcinomas in a previously characterized series of pancreatic carcinomas with known K-ras mutational status identified two additional cancers with poor differentiation, a syncytial growth pattern, and pushing borders. Both of the cancers were diploid and both patients were longterm survivors (over 5 years). The inclusion of such patients in previous prognostic studies of pancreas cancer may explain the failure of histological grade to be a predictor of prognosis. These data suggest that DNA replication errors occur in a small percentage of resected carcinomas of the pancreas and that wild-type K-ras gene status and a medullary phenotype characterized by poor differentiation, and expanding pattern of invasion, and syncytial growth should suggest the possibility of DNA replication errors in carcinomas of the pancreas.


This article has been cited by other articles:


Home page
J. Mol. Diagn.Home page
G. Feldmann and A. Maitra
Molecular Genetics of Pancreatic Ductal Adenocarcinomas and Recent Implications for Translational Efforts
J. Mol. Diagn., March 1, 2008; 10(2): 111 - 122.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Boyer Arnold and M. Korc
Smad7 Abrogates Transforming Growth Factor-{beta}1-mediated Growth Inhibition in COLO-357 Cells through Functional Inactivation of the Retinoblastoma Protein
J. Biol. Chem., June 10, 2005; 280(23): 21858 - 21866.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. A. Iacobuzio-Donahue, M. S. van der Heijden, M. R. Baumgartner, W. J. Troup, J. M. Romm, K. Doheny, E. Pugh, C. J. Yeo, M. G. Goggins, R. H. Hruban, et al.
Large-Scale Allelotype of Pancreaticobiliary Carcinoma Provides Quantitative Estimates of Genome-Wide Allelic Loss
Cancer Res., February 1, 2004; 64(3): 871 - 875.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
E. S. Calhoun, J. B. Jones, R. Ashfaq, V. Adsay, S. J. Baker, V. Valentine, P. M. Hempen, W. Hilgers, C. J. Yeo, R. H. Hruban, et al.
BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) Mutations in Distinct Subsets of Pancreatic Cancer: Potential Therapeutic Targets
Am. J. Pathol., October 1, 2003; 163(4): 1255 - 1260.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Rashid, T. Ueki, Y.-T. Gao, P. S. Houlihan, C. Wallace, B.-S. Wang, M.-C. Shen, J. Deng, and A. W. Hsing
K-ras Mutation, p53 Overexpression, and Microsatellite Instability in Biliary Tract Cancers: A Population-based Study in China
Clin. Cancer Res., October 1, 2002; 8(10): 3156 - 3163.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J.-H. Lee, S. C. Abraham, H.-S. Kim, J.-H. Nam, C. Choi, M.-C. Lee, C.-S. Park, S.-W. Juhng, A. Rashid, S. R. Hamilton, et al.
Inverse Relationship between APC Gene Mutation in Gastric Adenomas and Development of Adenocarcinoma
Am. J. Pathol., August 1, 2002; 161(2): 611 - 618.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. Nakata, Y. Qing Wang, M. Yashiro, N. Nishioka, H. Tanaka, M. Ohira, T. Ishikawa, H. Nishino, and K. Hirakawa
Prognostic Value of Microsatellite Instability in Resectable Pancreatic Cancer
Clin. Cancer Res., August 1, 2002; 8(8): 2536 - 2540.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. C. Abraham, T.-T. Wu, R. H. Hruban, J.-H. Lee, C. J. Yeo, K. Conlon, M. Brennan, J. L. Cameron, and D. S. Klimstra
Genetic and Immunohistochemical Analysis of Pancreatic Acinar Cell Carcinoma : Frequent Allelic Loss on Chromosome 11p and Alterations in the APC/{beta}-Catenin Pathway
Am. J. Pathol., March 1, 2002; 160(3): 953 - 962.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
K. M. Anderson and J. E. Harris
Selected Features of Nonendocrine Pancreatic Cancer
Experimental Biology and Medicine, June 1, 2001; 226(6): 521 - 537.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Yamamoto, F. Itoh, H. Nakamura, H. Fukushima, S. Sasaki, M. Perucho, and K. Imai
Genetic and Clinical Features of Human Pancreatic Ductal Adenocarcinomas with Widespread Microsatellite Instability
Cancer Res., April 1, 2001; 61(7): 3139 - 3144.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
A. C. Tersmette, G. M. Petersen, G. J. A. Offerhaus, F. C. Falatko, K. A. Brune, M. Goggins, E. Rozenblum, R. E. Wilentz, C. J. Yeo, J. L. Cameron, et al.
Increased Risk of Incident Pancreatic Cancer Among First-degree Relatives of Patients with Familial Pancreatic Cancer
Clin. Cancer Res., March 1, 2001; 7(3): 738 - 744.
[Abstract] [Full Text]


Home page
GutHome page
E EFTHIMIOU, T CRNOGORAC-JURCEVIC, N R LEMOINE, and T A BRENTNALL
Inherited predisposition to pancreatic cancer
Gut, February 1, 2001; 48(2): 143 - 147.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. Alexander, T. Watanabe, T.-T. Wu, A. Rashid, S. Li, and S. R. Hamilton
Histopathological Identification of Colon Cancer with Microsatellite Instability
Am. J. Pathol., February 1, 2001; 158(2): 527 - 535.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. J. C. Slebos, J. A. Hoppin, P. E. Tolbert, E. A. Holly, J. W. Brock, R. H. Zhang, P. M. Bracci, J. Foley, P. Stockton, L. M. McGregor, et al.
K-ras and p53 in Pancreatic Cancer: Association with Medical History, Histopathology, and Environmental Exposures in a Population-based Study
Cancer Epidemiol. Biomarkers Prev., November 1, 2000; 9(11): 1223 - 1232.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
R. H. Hruban, M. Goggins, J. Parsons, and S. E. Kern
Progression Model for Pancreatic Cancer
Clin. Cancer Res., August 1, 2000; 6(8): 2969 - 2972.
[Full Text]


Home page
Am. J. Pathol.Home page
R. E. Wilentz, M. Goggins, M. Redston, V. A. Marcus, N. V. Adsay, T. A. Sohn, S. S. Kadkol, C. J. Yeo, M. Choti, M. Zahurak, et al.
Genetic, Immunohistochemical, and Clinical Features of Medullary Carcinoma of the Pancreas : A Newly Described and Characterized Entity
Am. J. Pathol., May 1, 2000; 156(5): 1641 - 1651.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Ueki, M. Toyota, T. Sohn, C. J. Yeo, J.-P. J. Issa, R. H. Hruban, and M. Goggins
Hypermethylation of Multiple Genes in Pancreatic Adenocarcinoma
Cancer Res., April 1, 2000; 60(7): 1835 - 1839.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
R. E. Wilentz, G. H. Su, J. L. Dai, A. B. Sparks, P. Argani, T. A. Sohn, C. J. Yeo, S. E. Kern, and R. H. Hruban
Immunohistochemical Labeling for Dpc4 Mirrors Genetic Status in Pancreatic Adenocarcinomas : A New Marker of DPC4 Inactivation
Am. J. Pathol., January 1, 2000; 156(1): 37 - 43.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
D. S. LONGNECKER
Molecular Pathology of Invasive Carcinoma
Ann. N.Y. Acad. Sci., June 30, 1999; 880(1): 74 - 82.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Society for Investigative Pathology.